Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study
INTERVENTIONAL
Inicio: 4 de dic de 2015
ID: NCT02614196
Completado
Fase 3
ClinicalTrials.gov
A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability, and Efficacy Study of 3 Doses of Lecozotan (SRA-333) SR in Outpatients With Mild to Moderate Alzheimer's Disease Treated With a Cholinesterase Inhibitor
INTERVENTIONAL
Inicio: 1 de mar de 2006
ID: NCT00277810
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Open-label Phase II Multicenter Study Evaluating the Efficacy of Oral Everolimus Alone or in Combination With Pasireotide LAR i.m. in Advanced Progressive Pancreatic Neuroendocrine Tumors (PNET) - The COOPERATE-2 Study
INTERVENTIONAL
Inicio: 1 de jun de 2011
ID: NCT01374451
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy, Safety, Tolerability, PK, and Biomarker Effects of PTC857 in Adult Subjects With Amyotrophic Lateral Sclerosis (CARDINALS)
INTERVENTIONAL
Inicio: 15 de may de 2022
ID: NCT05349721
Completado
Fase 3
ClinicalTrials.gov
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
INTERVENTIONAL
Inicio: 31 de ago de 2007
ID: NCT00496769
Desconocido
ClinicalTrials.gov
An Extended Access Program for Perampanel
EXPANDED_ACCESS
ID: NCT01871233
Completado
Fase 3
ClinicalTrials.gov
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
INTERVENTIONAL
Inicio: 15 de mar de 2013
ID: NCT01737398
Reclutando
Fase 4
ClinicalTrials.gov
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress - The ASPIRE-AF Trial
INTERVENTIONAL
Inicio: 14 de jun de 2019
ID: NCT03968393
Terminado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Double-blind, Double-dummy, Active-comparator, Event-driven, Superiority Phase III Study of Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With a Recent Embolic Stroke of Undetermined Source (ESUS), Comparing Rivaroxaban 15 mg Once Daily With Aspirin 100 mg
INTERVENTIONAL
Inicio: 23 de dic de 2014
ID: NCT02313909
Completado
Fase 4
ClinicalTrials.gov
Bacillus Clausii in the Treatment of Acute Community-acquired Diarrhea Among Latin American Children (cadiLAc)
INTERVENTIONAL
Inicio: 1 de jul de 2014
ID: NCT02169817
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) Versus Investigator's Choice of Chemotherapy in Patients Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy in First-line Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION Breast02)
INTERVENTIONAL
Inicio: 16 de may de 2022
ID: NCT05374512
Completado
Fase 3
ClinicalTrials.gov
A Multi-country & Multi-center Study to Assess the Efficacy, Immunogenicity & Safety of Two Doses of GSK Biologicals' Oral Live Attenuated HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants
INTERVENTIONAL
Inicio: 1 de dic de 2003
ID: NCT00139347
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
INTERVENTIONAL
Inicio: 30 de abr de 2008
ID: NCT00699972
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomised Double-blind Placebo-controlled Clinical Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects With Early Alzheimer´s Disease (EVOKE)
INTERVENTIONAL
Inicio: 18 de may de 2021
ID: NCT04777396
Completado
ClinicalTrials.gov
Epilepsy Phenome/Genome Project: A Phenotype/Genotype Analysis of Epilepsy
OBSERVATIONAL
Inicio: 1 de nov de 2007
ID: NCT00552045
Completado
Fase 4
ClinicalTrials.gov
Phase 4 Study of a Reminiscence Program to Improve Quality of Life of Alzheimer's Disease Long Term Care Residents Using a Randomized Controlled Trial
INTERVENTIONAL
Inicio: 1 de ene de 2010
ID: NCT01295957
Completado
Fase 3
ClinicalTrials.gov
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate With Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation: Prospective, Multi-centre, Parallel-group, Non-inferiority Trial (RE-LY Study)
INTERVENTIONAL
Inicio: 1 de dic de 2005
ID: NCT00262600
Completado
Fase 3
ClinicalTrials.gov
Atazanavir (BMS-232632) for HIV Infected Individuals Completing Atazanavir Clinical Trials: An Extended Access Study
INTERVENTIONAL
Inicio: 1 de oct de 2002
ID: NCT01003990
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
INTERVENTIONAL
Inicio: 31 de dic de 2008
ID: NCT00725985
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
INTERVENTIONAL
Inicio: 27 de mar de 2014
ID: NCT02051608
Anterior
1
...
13
14
15
...
434
Siguiente
Filtros